Intro

This chapter examines the safety and complications of methotrexate in patients with systemic necrotizing vasculitis, emphasizing the heightened risk of serious infections based on data from various clinical trials. It also discusses risk factors for infections, including age and lung involvement, to guide medication decisions for at-risk patients.